PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-87.96%
Negative net income growth while CPAC stands at 37.87%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.30%
Some D&A expansion while CPAC is negative at -2.76%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-100.97%
Negative yoy deferred tax while CPAC stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.76%
Negative yoy SBC while CPAC is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-464.98%
Both reduce yoy usage, with CPAC at -389.09%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-434.04%
Both yoy AR lines negative, with CPAC at -936.59%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-443.95%
Both reduce yoy inventory, with CPAC at -27.66%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-1952.85%
Negative yoy AP while CPAC is 23.05%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-9.89%
Both reduce yoy usage, with CPAC at -293.79%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-33.77%
Both negative yoy, with CPAC at -27.31%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-135.43%
Both yoy CFO lines are negative, with CPAC at -113.26%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
3.25%
Lower CapEx growth vs. CPAC's 53.83%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-940.57%
Both yoy lines negative, with CPAC at -44.44%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-142.62%
Both yoy lines negative, with CPAC at -104.18%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-100.00%
We reduce yoy sales while CPAC is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-828.00%
Both yoy lines negative, with CPAC at -446.96%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-182.29%
We reduce yoy invests while CPAC stands at 38.61%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-37.70%
Both yoy lines negative, with CPAC at -73.33%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
100.00%
Issuance growth of 100.00% while CPAC is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
46.04%
Buyback growth of 46.04% while CPAC is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.